An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies.
about
Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratMolecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technologyRecombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain.The spike protein of SARS-CoV--a target for vaccine and therapeutic development.Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus.Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in miceRecombinant protein-based assays for detection of antibodies to severe acute respiratory syndrome coronavirus spike and nucleocapsid proteinsLongitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes.Comparison of immunoglobulin G responses to the spike and nucleocapsid proteins of severe acute respiratory syndrome (SARS) coronavirus in patients with SARSAnimal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions.Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV).Porcine Epidemic Diarrhea Virus Infection Inhibits Interferon Signaling by Targeted Degradation of STAT1.SARS-CoV genome polymorphism: a bioinformatics studyImportant role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entry.Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system.Development of an enzyme-linked immunosorbent assay-based test with a cocktail of nucleocapsid and spike proteins for detection of severe acute respiratory syndrome-associated coronavirus-specific antibody.Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design.Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agentsAnimal models and vaccines for SARS-CoV infection.Identification and characterization of a neutralizing-epitope-containing spike protein fragment in turkey coronavirus.Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses
P2860
Q24596042-2AAC04A4-EBA7-436D-862D-F68A3CC31352Q33210858-2B9763B9-FB11-4C74-8FC8-8BB3850F0BA1Q33688229-AA3439AA-F055-4FE2-A0F0-A732C96A7F22Q33834543-8C0A925C-29DD-45E5-B27B-A203427306E8Q33987417-5F4F96CF-F96E-406D-8153-5661C128F5B6Q34015988-8962C739-0033-4BF7-9846-9C1DEC64028BQ34301708-29310117-BD28-4B67-B213-BCF7EC211653Q34545911-09E1007E-85E6-4D80-B686-9E782BAEE3B9Q35690077-EF12609E-61D4-420D-BFA6-613B44715056Q35817398-06EB9DF9-C7EE-42E0-9AB5-C547EB71B3D2Q35946920-8D7A8887-F47A-4BB0-8E68-092B6743B268Q36447896-10380ACE-83CE-4FCD-9B38-6DF2020AA1C9Q37183997-91BFA8FC-EB6D-4B2A-BE82-CCCC437DFE9AQ38759478-D8EDB2CF-EA94-440A-9D8F-E49516097756Q39520199-80F3B910-9990-4F45-8BA8-820015D4E69AQ40329154-46E797F6-1E87-4F47-96C3-EE04130D996AQ40471278-510339C9-951A-4CA2-A819-6E4CA51A7C29Q42274000-133DC29D-C3B4-414A-957E-841D57BB8693Q42424192-1D2121E5-F059-47EA-9677-A2C6C4C3BB62Q42716746-9827149C-E4AC-4DC1-83F7-F1572F9AC452Q43152086-4EE2BEAD-27AD-43AD-87A6-6EA9B3359A9BQ43753428-FC062778-25BE-43C8-B9A5-82F4DA384AF7Q56552815-F2F0B5F4-8631-424C-983A-9387786F91A8
P2860
An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
An exposed domain in the sever ...... duces neutralizing antibodies.
@ast
An exposed domain in the sever ...... duces neutralizing antibodies.
@en
An exposed domain in the sever ...... duces neutralizing antibodies.
@nl
type
label
An exposed domain in the sever ...... duces neutralizing antibodies.
@ast
An exposed domain in the sever ...... duces neutralizing antibodies.
@en
An exposed domain in the sever ...... duces neutralizing antibodies.
@nl
prefLabel
An exposed domain in the sever ...... duces neutralizing antibodies.
@ast
An exposed domain in the sever ...... duces neutralizing antibodies.
@en
An exposed domain in the sever ...... duces neutralizing antibodies.
@nl
P2093
P2860
P1433
P1476
An exposed domain in the sever ...... duces neutralizing antibodies.
@en
P2093
Danlin Luo
Guoqiang Huang
Robert J Bunzel
Robert J Hogan
Shihong Qiu
Thomas G Voss
Thomas Rowe
P2860
P304
P356
10.1128/JVI.78.13.7217-7226.2004
P407
P577
2004-07-01T00:00:00Z